GeneDx Holdings Corp. (WGSWW)Stamford, United States | NasdaqGS
0.00 USD
+0.00
(0.000%)
⇧
(July 21, 2026, 3:59 p.m.
EDT)
|
Hot Take ↕ | Oct. 10, 2026, 7:42 a.m. EDT
The security is effectively worthless for investment purposes, trading at a fraction of a cent with zero price history to assess trends. Fundamentally, the company is in severe distress with negative operating margins, negative return on equity, and negative free cash flow, indicating a business that is currently destroying value rather than generating it. The balance sheet is precarious, with debt nearly matching total cash reserves, leaving no safety margin for operational missteps. While revenue growth appears positive, this is likely a statistical anomaly given the tiny absolute dollar amounts and the overall negative profitability. There is no dividend to provide income, and the lack of any price trajectory or analyst support suggests the market has priced out any remaining value. This is a speculative gamble on a turnaround that has not yet materialized, making it unsuitable for any rational investment strategy. |
| Attribute | Value |
|---|---|
| Debt to Equity Ratio | 66.185 |
| Revenue per Share | 15.297 |
| Beta | 1.91 |
| Profit Margins | -17.58% |
| Previous Name | Mount Sinai Genomics, Inc. |
| Website | https://www.genedx.com |
| Attribute | Value |
|---|---|
| Address1 | North Tower |
| Address2 | 6th Floor 333 Ludlow Street |
| Ask | 0.0 |
| Ask Size | 0 |
| Beta | 1.911 |
| Bid | 0.0 |
| Bid Size | 0 |
| Book Value | 8.566 |
| City | Stamford |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.0002 |
| Current Ratio | 3.088 |
| Custom Price Alert Confidence | HIGH |
| Day High | 0.0012 |
| Day Low | 0.0002 |
| Debt To Equity | 66.185 |
| Ebitda | -7,850,000 |
| Ebitda Margins | -0.01773 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 201 421 2010 |
| Fifty Two Week High | 0.0012 |
| Fifty Two Week High Change | -0.001 |
| Fifty Two Week High Change Percent | -0.8333333 |
| Fifty Two Week Low | 0.0002 |
| Fifty Two Week Low Change | 0.0 |
| Fifty Two Week Low Change Percent | 0.0 |
| Fifty Two Week Range | 2.0E-4 - 0.0012 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,784,295,000,000 |
| Float Shares | 18,935,914 |
| Free Cashflow | 3,643,375 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 1,300 |
| Fullday Change | 0.0002 |
| Fullday Change Percent | 0.0 |
| Fullday Price | 0.0002 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.69557 |
| Gross Profits | 307,912,992 |
| Has Pre Post Market Data | 1 |
| Industry | |
| Industry Key | |
| Language | en-US |
| Long Business Summary | GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut. |
| Long Name | GeneDx Holdings Corp. |
| Market | us_market |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_608642327 |
| Name Change Date | 2,026-10-14 |
| Net Income To Common | -77,808,000 |
| Open | 0.0762 |
| Operating Cashflow | -9,311,000 |
| Operating Margins | -0.25607002 |
| Phone | 888 729 1206 |
| Prev Name | Mount Sinai Genomics, Inc. |
| Previous Close | 0.0 |
| Price Hint | 4 |
| Price To Book | 0.00002334812 |
| Profit Margins | -0.17577 |
| Quick Ratio | 2.825 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0002 |
| Regular Market Change Percent | 0.0 |
| Regular Market Day High | 0.0012 |
| Regular Market Day Low | 0.0002 |
| Regular Market Day Range | 2.0E-4 - 0.0012 |
| Regular Market Open | 0.0762 |
| Regular Market Previous Close | 0.0 |
| Regular Market Price | 0.0002 |
| Regular Market Time | 1,784,663,951 |
| Regular Market Volume | 1,665,188 |
| Return On Assets | -0.0437 |
| Return On Equity | -0.30422002 |
| Revenue Growth | 0.174 |
| Revenue Per Share | 15.297 |
| Sand P52 Week Change | 0.17502642 |
| Sector | |
| Sector Key | |
| Short Name | GeneDx Holdings Corp. |
| Source Interval | 15 |
| State | CT |
| Symbol | WGSWW |
| Total Cash | 170,684,992 |
| Total Cash Per Share | 5.749 |
| Total Debt | 168,192,000 |
| Total Revenue | 442,678,016 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | NaN |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Type Disp | Equity |
| Volume | 1,665,188 |
| Website | https://www.genedx.com |
| Zip | 6,902 |